Published online Apr 28, 2026. doi: 10.4329/wjr.v18.i4.118196
Revised: January 21, 2026
Accepted: February 4, 2026
Published online: April 28, 2026
Processing time: 119 Days and 0.9 Hours
This letter to the editor discusses a recent multi-institutional study that developed a noninvasive deep learning-based radiomics score derived from preoperative magnetic resonance imaging (MRI) to predict event-free survival in pediatric hepatoblastoma. The original study by Yang and Li published in World Journal of Radiology, leveraged convolutional neural networks to extract high-dimensional features from T1 and T2 sequences, the researchers developed an integrated nomogram that combines these imaging signatures with traditional markers like alpha-fetoprotein and the pretreatment extension of disease stage. This model significantly out
Core Tip: Accurate preoperative risk stratification remains challenging in pediatric hepatoblastoma. This study demonstrates that a magnetic resonance imaging-based deep learning radiomics score predicts event-free survival and refines risk stratification beyond conventional clinical factors. Integration with pretreatment extension of disease stage and alpha-fetoprotein improves prognostic accuracy, supporting noninvasive, imaging-driven decision-making for individualized.
